» Articles » PMID: 16081278

E2F-Rb Complexes Regulating Transcription of Genes Important for Differentiation and Development

Overview
Publisher Elsevier
Specialties Biology
Genetics
Date 2005 Aug 6
PMID 16081278
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Inactivation of the retinoblastoma tumour suppressor protein (pRb) is a hallmark of most human cancers. Accordingly, pRb is serving as a paradigm in our quest to understand tumour suppressor function. The role played by pRb and the related 'pocket proteins', p107 and p130, in regulating cell cycle progression has been extensively studied over the past two decades. The function of pRb in regulating transcriptional programmes in differentiating cells is less well understood. Recently, the use of a variety of different cell, animal and plant model systems has allowed us a first glimpse at some of the molecular mechanisms underlying pRb-mediated transcriptional regulation during differentiation and development.

Citing Articles

Gill regeneration in the mayfly uncovers new molecular pathways in insect regeneration.

Martin-Blanco C, Navarro P, Esteban-Collado J, Serra F, Almudi I, Casares F Open Biol. 2024; 14(11):240118.

PMID: 39591992 PMC: 11597413. DOI: 10.1098/rsob.240118.


Epigenetic Reprogramming and Inheritance of the Cellular Differentiation Status Following Transient Expression of a Nonfunctional Dominant-Negative Retinoblastoma Mutant in Murine Mesenchymal Stem Cells.

Baryshev M, Maksimova I, Sasoveca I Int J Mol Sci. 2024; 25(19).

PMID: 39409007 PMC: 11476944. DOI: 10.3390/ijms251910678.


Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9.

Ma Z, Li Q, Wang W, Deng Z Int J Oncol. 2024; 65(4).

PMID: 39239750 PMC: 11387118. DOI: 10.3892/ijo.2024.5686.


The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.

Chang C, Liu F, Militi S, Hester S, Nibhani R, Deng S Nat Commun. 2024; 15(1):3580.

PMID: 38678032 PMC: 11055877. DOI: 10.1038/s41467-024-47680-z.


Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer.

Gildiz S, Minko T Pharm Res. 2022; 40(1):123-144.

PMID: 36376606 PMC: 9663189. DOI: 10.1007/s11095-022-03434-4.